23.33

0.34% 0.08

Ceribell Inc (CBLL)

Overview News Price History Discussions Forecast

Ceribell Inc stock is traded at $23.33, with a volume of 296.04K. It is up +0.34% in the last 24 hours and up +21.96% over the past month. CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Previous Close:

$23.25

Open:

$23.25

24h Volume:

296.04K

Relative Volume:

0.76

Market Cap:

$895.36M

Revenue:

$95.07M

Net Income/Loss:

$-60.37M

P/E Ratio:

-14.32

EPS:

-1.6291

Net Cash Flow:

$-50.92M

1W Performance:

+24.03%

1M Performance:

+21.96%

6M Performance:

+18.01%

1Y Performance:

+97.88%

1-Day Range:

$23.03

$23.55

1-Week Range:

$18.64

$23.55

52-Week Range:

$10.85

$24.33

Ceribell Inc Stock (CBLL) Company Profile

Name

Ceribell Inc

Sector

Healthcare (1080)

Industry

Medical Devices (141)

Phone

(800) 436-0826

Address

360 N. PASTORIA AVENUE, SUNNYVALE

Employee

300

Twitter

Next Earnings Date

2026-08-10

Latest SEC Filings

CBLL's Discussions on Twitter

Compare CBLL vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CBLL Ceribell Inc	23.33	879.24M	95.07M	-60.37M	-50.92M	-1.6291
ABT Abbott Laboratories	111.25	191.92B	46.59B	5.41B	7.38B	3.0938
SYK Stryker Corp	339.21	133.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	91.27	116.18B	36.36B	4.84B	5.43B	3.7261
BSX Boston Scientific Corp	51.83	74.52B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	91.60	53.63B	6.30B	1.07B	1.09B	1.8406

Ceribell Inc Stock (CBLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-21-25	Initiated	Raymond James	Strong Buy
Jun-24-25	Initiated	BTIG Research	Buy
Apr-04-25	Initiated	Ladenburg Thalmann	Buy
Nov-05-24	Initiated	BofA Securities	Buy
Nov-05-24	Initiated	Canaccord Genuity	Buy
Nov-05-24	Initiated	JP Morgan	Overweight
Nov-05-24	Initiated	TD Cowen	Buy
Nov-05-24	Initiated	William Blair	Outperform

View All

Ceribell Inc Stock (CBLL) Latest News

Aug 14, 2026

Ceribell Director Joseph Michael Taylor Sells 13,095 Shares at $23.4 Each - Kalkine Media

Aug 14, 2026

Ceribell director Joseph Taylor sells $306,423 in company stock - Investing.com

Aug 14, 2026

CeriBell (NASDAQ:CBLL) Director Joseph Michael Taylor Sells 13,095 Shares - MarketBeat

Aug 14, 2026

Ceribell director Joseph Taylor sells $306,423 in company stock By Investing.com - Investing.com Canada

Aug 14, 2026

Aug 13, 2026

Ceribell (CBLL) director sells 13,095 shares of common stock at $23.40 - Stock Titan

Aug 13, 2026

Aug 12, 2026

CeriBell (NASDAQ:CBLL) Trading Up 9.7%Here's Why - MarketBeat

Aug 12, 2026

Analysts’ Opinions Are Mixed on These NA Stocks: Cardinal Infrastructure Group, Inc. (CDNL), Arcturus Therapeutics (ARCT) and Ceribell, Inc. (CBLL) - The Globe and Mail

Aug 12, 2026

Ceribell Wins FDA Nod for AI Tools on Its Neurology Portal - Medical Product Outsourcing

Aug 12, 2026

CeriBell at canaccord growth conference: sees long runway ahead By Investing.com - Investing.com Canada

Aug 12, 2026

CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push - MarketBeat

Aug 12, 2026

CeriBell at canaccord growth conference: sees long runway ahead - Investing.com

Aug 12, 2026